基于FDA不良事件报告系统 (FAERS) 和孟德尔随机化研究的Levothyroxine的营销后药监测研究
Bingyu Ma1, Zhengjun Ma1, Pengfei Liang1
1Department of Pharmacy, Heze University, Heze, Shandong Province, 274000, China.
Naunyn-Schmiedeberg's archives of pharmacology
|December 5, 2025
概括
这项研究使用FAERS数据确定了levothyroxine的新不良事件,包括头和自身免疫甲状腺炎. 门德尔随机化证实了诸如乳病和偏头痛等疾病的因果关系.
科学领域:
- 药监和药物安全 药监和药物安全
- 临床药理学 临床药理学
- 流行病学 流行病学
背景情况:
- 利沃甲状腺素是一种广泛处方的甲状腺功能低下症药物.
- 营销后监测对于识别罕见或意想不到的药物不良反应至关重要.
- 现有的关于levothyroxine不良事件的数据可能不是详尽的.
研究的目的:
- 使用现实数据识别和评估与levothyroxine相关的营销后不良事件.
- 评估莱沃西和已确定不良事件之间的潜在因果关系.
主要方法:
- 利用FDA不良事件报告系统 (FAERS) 数据库进行不良事件记录.
- 应用了四种药监信号检测方法:ROR,PRR,BCPNN和MGPS.
- 进行了两样本的孟德尔随机化 (MR) 分析以评估因果关系.
主要成果:
- 确定了目前的levothyroxine处方信息中没有列出的几个不良事件,包括头,抑郁症,肌痛,偏头痛,腹,乳糖不耐受,自身免疫性甲状腺炎和指甲疾病.
- 核磁共振分析表明,勒沃西与肌痛,偏头痛,腹病,乳糖不耐症和自身免疫性甲状腺炎之间存在因果关系.
- 强调需要加强对这些潜在不良反应的临床警.
结论:
- 利沃甲素使用与一些以前未报告的不良事件有关.
- 确认了特定不良事件的因果关系,需要更新临床指南和患者咨询.
- 这些发现为最大限度地降低临床风险和改善Levothyroxine治疗期间的患者安全提供了关键信息.
相关概念视频
01:19Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
01:29Therapeutic Drug Monitoring: Affecting Factors
182
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
182
01:25Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
01:20Synthesis and Regulation of Thyroid Hormones
7.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.1K
01:16Therapeutic Drug Monitoring: Overview and Classification
275
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
275
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
164
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
164